Identification of novel HLA-A*11:01-restricted HPV16 E6/E7 epitopes and T-cell receptors for HPV-related cancer immunotherapy

BACKGROUND: E6 and E7 oncoproteins are considered ideal antigens of T cell therapy for human papillomavirus (HPV)-related cancers. However, little is known about the epitopes of E6 and E7 presented by HLA-A*11:01, one of the most prevalent HLA types globally, especially in Asia. METHODS: We combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Chengjie, Huang, Lihong, Kou, Hedan, Wang, Chenwei, Zeng, Xiaomin, Sun, Hanli, Liu, Shangyuan, Wu, Bin, Li, Jingyao, Wang, Xiaoling, Wang, Zibing, Chen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528665/
https://www.ncbi.nlm.nih.gov/pubmed/36180070
http://dx.doi.org/10.1136/jitc-2022-004790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528665/
https://www.ncbi.nlm.nih.gov/pubmed/36180070
http://dx.doi.org/10.1136/jitc-2022-004790

Ejemplares similares